List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 86 studies with search of: Open Studies | "Peritoneal Dialysis"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Not yet recruiting The Effect of Intra-abdominal t-PA and and DNase on Peritonitis in Peritoneal Dialysis Patients
Conditions: Peritoneal Dialysis;   Peritoneal Dialysis, Continuous Ambulatory
Interventions: Drug: Tissue Plasminogen Activator (tPA);   Drug: recombinant deoxyribonuclease (DNase)
2 Recruiting Comparison of Quality of Life on Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis
Conditions: End Stage Renal Disease;   Peritoneal Dialysis
Intervention:
3 Unknown † Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
Conditions: Renal Failure, End Stage;   Peritoneal Dialysis
Intervention: Drug: Simvastatin
4 Unknown † Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
Conditions: End-Stage Kidney Disease;   Peritoneal Dialysis
Intervention: Drug: N-acetylcysteine
5 Unknown † Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
Condition: Peritoneal Dialysis
Intervention: Drug: alendronate (Fosamax)
6 Unknown † Effect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients
Conditions: ESRD;   Peritoneal Dialysis
Intervention: Drug: Oral N-Acetylcysteine 1200 mg x 2/day for 4 weeks.
7 Unknown † Bioimpedance as a Tool for Fluid Management in Peritoneal Dialysis (PD) Patients
Conditions: Fluid Status;   Peritoneal Dialysis
Intervention:
8 Recruiting Effect of Bio-impedance Analysis and Vitamin D vs Usual Care on Left Ventricular Mass in Peritoneal Dialysis Patients: A Randomized Controlled Trial (FLUID Study)
Condition: Peritoneal Dialysis
Interventions: Drug: Bioimpedance and Vitamin D;   Drug: Usual care and placebo;   Drug: Usual care and Vitamin D;   Device: Bioimpedance and Placebo
9 Recruiting Prevention of Peritonitis in Peritoneal Dialysis
Conditions: Kidney Failure, Chronic;   Peritoneal Dialysis-associated Peritonitis;   Dialysis Capd Infection
Intervention: Behavioral: Follow-up of PD patients´ theoretical and practical skills
10 Unknown † Study to Evaluate the Protective Effect of α-Keto Acid With Low-Protein Diet (LPD) on Renal Function (RRF) in Peritoneal Dialysis (PD) Patients
Condition: Continuous Ambulatory Peritoneal Dialysis
Interventions: Dietary Supplement: α-Keto Acid with low protein diet;   Dietary Supplement: Normal protein diet
11 Not yet recruiting The Effects Nutrition Status and Body Composition On Peritoneal Dialysis Outcome
Condition: Peritoneal Dialysis
Intervention:
12 Recruiting Diurnal Variation of Mineral Metabolism and Protein Fermentation Metabolites in Peritoneal Dialysis Patients and Healthy Volunteers
Condition: Peritoneal Dialysis
Intervention:
13 Recruiting Comparison of Outcomes Between Hemodialysis and Peritoneal Dialysis Patients in a Multi-Ethnic Asian Population
Conditions: Stage 5 Chronic Kidney Disease;   Hemodialysis;   Peritoneal Dialysis
Intervention:
14 Unknown † The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients
Condition: Continuous Ambulatory Peritoneal Dialysis
Interventions: Drug: Enalapril;   Drug: Enalapril plus Losartan;   Drug: Placebo
15 Recruiting Natural History of Mineral Metabolism Parameters and Protein-bound Toxins in Incident Peritoneal Dialysis Patients
Condition: Complication of Peritoneal Dialysis
Intervention:
16 Recruiting The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis
Conditions: Peritoneal Dialysis;   Hemodialysis
Intervention:
17 Unknown † Relationship of Peritoneal Solute Transport Rate With VEGF in Children Undergoing Peritoneal Dialysis
Condition: Peritoneal Dialysis
Intervention:
18 Not yet recruiting Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis
Conditions: Rate of Exit Site Infection;   Rate of Atypical Mycobacterial Infection;   Rate of Peritoneal Dialysis
Interventions: Drug: gentamicin;   Drug: gentamicin cream alternating with mupirocin cream
19 Unknown † Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
Conditions: End Stage Renal Disease;   Insulin Resistance
Interventions: Drug: PD solution;   Drug: PD solution containing L-carnitine
20 Unknown † Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
Conditions: End Stage Renal Disease;   Diabetes
Interventions: Drug: PD Solution;   Drug: PD solution containing L-carnitine

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services